BioLife Solutions, Inc. (BLFS)
NASDAQ: BLFS · Real-Time Price · USD
22.72
+0.39 (1.75%)
Jul 10, 2025, 4:00 PM - Market closed
BioLife Solutions Stock Forecast
Stock Price Forecast
The 7 analysts that cover BioLife Solutions stock have a consensus rating of "Strong Buy" and an average price target of $30.57, which forecasts a 34.55% increase in the stock price over the next year. The lowest target is $27 and the highest is $33.
Price Target: $30.57 (+34.55%)
Analyst Consensus: Strong Buy
* Price targets were last updated on May 13, 2025.
Analyst Ratings
The average analyst rating for BioLife Solutions stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 6 | 6 | 5 | 5 | 5 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 8 | 8 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +32.04% | May 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $27 → $30 | Strong Buy | Maintains | $27 → $30 | +32.04% | Mar 6, 2025 |
| Northland Capital Markets | Northland Capital Markets | Buy Maintains $28 → $31 | Buy | Maintains | $28 → $31 | +36.44% | Jan 8, 2025 |
| Benchmark | Benchmark | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +32.04% | Dec 19, 2024 |
| Keybanc | Keybanc | Buy Maintains $30 → $33 | Buy | Maintains | $30 → $33 | +45.25% | Dec 13, 2024 |
Financial Forecast
Revenue This Year
99.70M
from 82.25M
Increased by 21.21%
Revenue Next Year
117.23M
from 99.70M
Increased by 17.58%
EPS This Year
-0.10
from -0.44
EPS Next Year
0.07
from -0.10
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 103.6M | 126.4M | 151.2M | ||
| Avg | 99.7M | 117.2M | 145.9M | ||
| Low | 95.3M | 109.8M | 139.3M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 26.0% | 26.8% | 29.0% | ||
| Avg | 21.2% | 17.6% | 24.5% | ||
| Low | 15.8% | 10.1% | 18.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.06 | 0.13 | 0.53 |
| Avg | -0.10 | 0.07 | 0.51 |
| Low | -0.14 | 0.02 | 0.49 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | 614.9% |
| Avg | - | - | 594.4% |
| Low | - | - | 567.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.